Adrenaline 0.5mg IM in CAD Anaphylaxis
Administer adrenaline 0.3-0.5mg intramuscularly in the anterolateral thigh immediately for anaphylaxis, even in patients with coronary artery disease—there is no absolute contraindication to epinephrine in anaphylaxis, and the mortality risk from untreated anaphylaxis far exceeds the cardiac risk from appropriate IM dosing. 1, 2
Dosing and Administration
The standard adult dose remains 0.3-0.5mg (0.3-0.5mL of 1:1000 solution) intramuscularly into the anterolateral thigh, repeated every 5-10 minutes as necessary 1, 2. This applies regardless of CAD status.
Key Points for CAD Patients:
- IM epinephrine at recommended doses is safe: The cardiac complications reported in literature primarily involve intravenous administration or overdosing, not appropriate IM dosing 3, 4, 5
- Intramuscular route is critical: IM injection in the thigh produces rapid, predictable plasma levels without the dangerous peaks associated with IV boluses 6, 7
- Untreated anaphylaxis is more dangerous: Cardiovascular collapse from anaphylaxis poses greater mortality risk than the theoretical cardiac complications from properly dosed IM epinephrine 1, 7
Monitoring Considerations for CAD Patients
While administering IM epinephrine, implement these safeguards:
- Close hemodynamic monitoring is recommended for all anaphylactic shock patients 1
- Monitor blood pressure and pulse every minute if possible
- Obtain ECG monitoring when available 6
- Watch for chest pain, arrhythmias, or signs of myocardial ischemia
When to Consider IV Epinephrine (High-Risk Scenario)
IV epinephrine should ONLY be used in CAD patients who are:
- In cardiac arrest, OR
- Profoundly hypotensive AND have failed to respond to multiple IM doses AND IV fluid resuscitation 6
If IV epinephrine becomes necessary:
- Use 0.05-0.1mg (0.5-1mL of 1:10,000 dilution) slowly over several minutes 6
- Alternatively, prepare an infusion: 1mg in 250mL D5W, starting at 1-4μg/min, titrating to effect (maximum 10μg/min) 6
- Continuous cardiac monitoring is mandatory 6
Critical Pitfalls to Avoid
The most dangerous error is confusing anaphylaxis dosing with cardiac arrest dosing 3:
- Anaphylaxis: 0.3-0.5mg IM (1:1000 solution)
- Cardiac arrest: 1mg IV (1:10,000 solution)
Inadvertent IV administration of the higher concentration has caused coronary vasospasm, stress cardiomyopathy, and acute MI even in young healthy patients 4, 5. In CAD patients, this risk is amplified but remains associated with dosing errors, not appropriate IM administration 5.
Additional Supportive Measures
After epinephrine administration:
- Position patient supine with legs elevated (improves venous return)
- Aggressive IV fluid resuscitation: 1-2L normal saline rapidly in adults (5-10mL/kg in first 5 minutes) 6
- High-flow oxygen at 6-8L/min 6
- Consider glucagon 1-5mg IV if patient is on beta-blockers, as this can complicate epinephrine response 6
The Bottom Line
Do not withhold or reduce IM epinephrine dosing in CAD patients experiencing anaphylaxis. The evidence consistently shows that appropriate IM dosing (0.3-0.5mg) is safe, while delayed or inadequate epinephrine contributes to anaphylaxis fatalities 1, 7, 8. Cardiac complications arise from IV overdosing or administration errors, not from guideline-concordant IM treatment 3, 4.